$0.50 +0.02 (%) Palatin Technologies Inc - NYSE Amex Equities

Aug. 26, 2016 | 02:37 PM

Partner Headlines

  1. The New Female Libido Drug: Hot or Hype?

    FoxBusiness | Sep. 9, 2015 | 13:29PM EST
  2. Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction

    Benzinga | Aug. 18, 2015 | 20:51PM EST
  3. Chuck Royce Cuts Second Largest Communications Equipement Holding

    GuruFocus | Jul. 7, 2015 | 21:27PM EST
  4. Investor Chuck Royce Cuts Stake in Adtran

    GuruFocus | Jul. 7, 2015 | 21:27PM EST
  5. Worst Performing Industries For June 16, 2015

    Benzinga | Jun. 16, 2015 | 11:36AM EST
  6. Earnings Scheduled For February 13, 2015

    Benzinga | Feb. 13, 2015 | 05:09AM EST
  7. Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

    Benzinga | Dec. 29, 2014 | 07:31AM EST
  8. Earnings Scheduled For September 9, 2014

    Benzinga | Sep. 9, 2014 | 05:24AM EST
  9. Palatin Technologies Contacted by NYSE Regarding Market Activity

    Benzinga | Jan. 13, 2014 | 16:32PM EST
  10. Earnings Scheduled For September 30, 2013

    Benzinga | Sep. 30, 2013 | 05:32AM EST
  11. Palatin Technologies, Inc. (PTN) CFO Stephen T Wills buys 10,000 Shares

    GuruFocus | Jan. 2, 2013 | 09:06AM EST
  12. Palatin Technologies, Inc. (PTN) CEO Carl Spana buys 10,000 Shares

    GuruFocus | Jan. 2, 2013 | 09:06AM EST
  13. Benzinga's Microcap Movers for Thursday November 8, 2012

    Benzinga | Nov. 8, 2012 | 15:06PM EST
  14. Palatin Technologies Reports Positive Phase 2B Results for Bremelanotide in Female Sexual Dysfunction Trial

    Benzinga | Nov. 8, 2012 | 01:22AM EST
  15. Earnings Scheduled For September 11, 2012

    Benzinga | Sep. 10, 2012 | 18:16PM EST
  16. WESCO International, LaSalle Hotel Properties Among Stocks Gapping Down Thursday

    FoxBusiness | Jul. 19, 2012 | 04:31AM EST
  17. Benzinga's Microcap Movers for Friday July 6, 2012

    Benzinga | Jul. 6, 2012 | 10:54AM EST
  18. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration

    Benzinga | Jun. 19, 2012 | 01:33AM EST
Trading Center